Introduction {#sec1}
============

Gastric cancer (GC) is one of the most common malignant cancers worldwide -- it occupies the fourth position according to incidence and the second according to mortality \[[@cit0001], [@cit0002]\]. Within the last decades a decrease has been observed in the incidence of GC, which is due to higher standards of hygiene, better food preservation, high consumption of fresh fruits and vegetables, as well as eradication of *Helicobacter pylori* \[[@cit0001]\]. The majority of cases of GC are closely associated with environmental factors, such as tobacco smoking, alcohol abuse, infection with *Helicobacter pylori*, or Epstein-Barr virus \[[@cit0001]\]. Unmodifiable risk factors of GC are family history of GC, advanced age, male gender, low socioeconomic status and history of partial gastrectomy \[[@cit0001]\]. The prognosis in patients with GC is unfavourable, because of late detection. In the European countries 5-year survival rates range from 10 to 30%, whereas these rates are relatively high in Japan -- approximately 90%. This is probably related to an early endoscopic diagnosis and resection of the tumour at its initial stage \[[@cit0001]\]. Surgical treatment is the main method of management of patients with locally advanced GC. The selection of the type of surgical procedure depends on the clinical stage (cTNM), degree of differentiation and location of the tumour. The 5-year survival of patients with GC remains an important clinical problem which requires further research in order to seek new treatment methods, especially neoadjuvant therapy \[[@cit0003]\].

Intraperitoneal dissemination is the typical mechanism of formation of metastases in GC \[[@cit0004]\]. Intraperitoneal recurrence is observed in 32--54% of patients \[[@cit0005]\]. According to the 8th edition of the TNM classification for GC by the American Joint Committee of Cancer (AJCC), the detection of cancer cells in cytological preparations from puncture of the peritoneal cavity (in the case of ascites) categorizes this characteristic as M1 \[[@cit0006]\]. In the 13^th^ edition of the Japanese Classification of Gastric Carcinoma, the presence of free intraperitoneal cancer cells in the peritoneal cavity is classified as stage IV disease \[[@cit0007]\].

The stages of development of intraperitoneal dissemination are demonstrated by Paget's 'seed and soil' theory. Initially, cancer cells disconnect from the primary tumour and migrate to the peritoneum, where they attach to the mesothelial cells. The subsequent stage is their invasion through the basement membrane into the subperitoneal tissue and proliferation with angiogenesis \[[@cit0004]\].

Intraperitoneal free cancer cells (IFCCs) are cells which have detached from the primary tumour through exfoliation from its surface into the peritoneal cavity \[[@cit0007]\]. This process is caused, among other things, by a decrease in expression of adhesion proteins in GC cells \[[@cit0004]\]. The majority of IFCCs, after binding to the peritoneum, die due to poor nutrition and lack of vascularization. However, due to the CD44 adhesive particles on their surface, changes occur in the cytoskeleton of the cell and its migration into the subperitoneal space. Cancer cells strongly bind to the exposed basement membrane of the peritoneal epithelium. Subsequently, they secrete proteinases degrading the peritoneal-blood barrier and penetrate deeper into the subperitoneal tissue. A further stage of invasion is the formation of new blood vessels which nourish the newly established intraperitoneal metastasis. The privileged sites, where intraperitoneal metastases are formed earlier, are the peritoneal lymphatic orifices. The IFCCs migrate through the lymphatic orifices into the lymphatic subperitoneal space and there they proliferate. There are many lymphatic orifices on the surface of the greater omentum, epiploic appendices of the colon, the lower surface of the diaphragm, falciform ligament of the liver, the pouch of Douglas, and the mesentery of the small intestine. At these sites, intraperitoneal metastases are more frequently observed. For comparison, on the parietal peritoneum or visceral peritoneum of the small intestine, liver and spleen, the number of lymphatic peritoneal orifices is smaller, and at these sites metastases into the peritoneum are observed as late as in advanced stages of intraperitoneal dissemination \[[@cit0007]\].

The source of IFCCs may also be iatrogenic -- an improper surgical technique during the resection of the tumour may lead to dissemination of the IFCCs in the peritoneal cavity. Cancer cells are released from the cut lymphatic vessels, dissected tissue from the margin of cancer resection, as well as blood from the tumour which got into the surgical site \[[@cit0007]\]. This phenomenon has been confirmed by many studies using peritoneal lavage cytology prior to and after gastrectomy \[[@cit0004], [@cit0008]\].

The prognostic importance of IFCCs in GC remains unclear \[[@cit0009]\]. The objective of the study is to analyse the mechanism of formation, methods of detection, and clinical and prognostic importance of IFCCs in GC.

Material and methods {#sec2}
====================

Scientific reports were searched for in the PubMed database. The following key words were entered: free cancer cells, gastric cancer, peritoneal lavage gastric cancer, peritoneal cytology gastric cancer, intraperitoneal cancer cells gastric cancer, obtaining a total of 3,106 results. After the use of the filters clinical trial, comparative study, meta-analysis, controlled clinical trial, observational study, RCT, 421 results were obtained. Subsequently, the filter was applied considering reports published within the last 10 years, obtaining 232 results. These results were subjected to analysis of their relevance to the subject of the study. As a result of the analysis, 19 scientific reports were included in the review. The data from the algorithm presented below ([Fig. 1](#f0001){ref-type="fig"}) were presented in the form of tables ([Tables 1](#t0001){ref-type="table"} and [2](#t0002){ref-type="table"}) and a meta-analysis ([Fig. 2](#f0002){ref-type="fig"}).

###### 

Compilation of scientific reports

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No.                               First author                    Year of publication   No. of patients   Diagnostic method                 Treatment applied                  Positive result *n* (%)   Survival                                                                                                                 
  --------------------------------- ------------------------------- --------------------- ----------------- --------------------------------- ---------------------------------- ------------------------- ------------------------------------------------------------------------------------------------------------------------ --
  1                                 Kuramato \[[@cit0010]\]         2009                  1522              Cytology                          Lack                               88 (5.8)                  5-year survival: surgical treatment: 4.6% surgical treatment + intraperitoneal chemotherapy + peritoneal lavage: 43.8%   

  2                                 Hao \[[@cit0011]\]              2010                  83                Cytology + RT-PCR                 Laparoscopic gastrectomy           33 (39.2)                 Median survival: presence of IFCCs: 20 months                                                                            

                                                                                          81                                                  Classical gastrectomy              36 (44.3)                 lack of IFCCs: 31 months                                                                                                 

  3                                 La Torre \[[@cit0012]\]         2010                  64                Cytology                          Lack                               7 (11)                    Median: 32 months\                                                                                                       
                                                                                                                                                                                                           5-year: 28%                                                                                                              

  4                                 Lorenzen \[[@cit0013]\]         2010                  61                Cytology                          Before neo-CTH                     19 (31)                   Median survival: 9.2 months\                                                                                             
                                                                                                                                                                                                           2-year survival: 2                                                                                                       

  5                                 Homma \[[@cit0014]\]            2010                  992               Cytology                          Before gastrectomy                 62 (6.25)                                                                                                                                          

  6                                 Han \[[@cit0005]\]              2011                  38                Cytology                          Before gastrectomy                 13 (34.2)                                                                                                                                          

  After gastrectomy                 15 (39.5)                                                                                                                                                                                                                                                                                       

  7                                 Fujiwara \[[@cit0015]\]         2011                  25                Cytology                          CTH systemic and intraperitoneal   11 (44)                                                                                                                                            

  8                                 Noda \[[@cit0016]\]             2011                  1562              Cytology                          Lack                               179 (11.5)                                                                                                                                         

  9                                 Lee \[[@cit0017]\]              2011                  1072              Cytology                          After gastrectomy                  172 (16)                                                                                                                                           

  10                                Wong \[[@cit0018]\]             2012                  156               Cytology                          Lack                               31 (19.9)                                                                                                                                          

                                                                                                            RT-PCR                                                               58 (37.2)                                                                                                                                          

  11                                Cotte \[[@cit0009]\]            2013                  200               Cytology                          neo-CTH in 2 patients              39 (19.5)                 Presence of IFCCs in cytological examination is not an independent prognostic factor                                     

  12                                Mezhir \[[@cit0019]\]           2013                  22                Cytology                          Lack                               12 (54.5)                                                                                                                                          

  13                                Takebayashi \[[@cit0020]\]      2014                  102               Cytology + RT-CR + cell culture   Before gastrectomy                 45 (44.2)                                                                                                                                          

  After gastrectomy                 80 (78.4)                                                                                                                                                                                                                                                                                       

  14                                Fuijwara Y \[[@cit0021]\]       2014                  137               Cytology                          aCTH                               27 (20)                   Worse prognoses in patients with positive RT-PCR                                                                         

                                                                                                            RT-PCR                                                               59 (54)                                                                                                                                            

  15                                Kano \[[@cit0022]\]             2015                  1039              Cytology                          Lack                               116 (11)                  2-year survival: 22.9%\                                                                                                  
                                                                                                                                                                                                           median survival: 11 months                                                                                               

  16                                Pak \[[@cit0023]\]              2017                  48                Cytology                          Lack                               10 (21)                   2-year survival:\                                                                                                        
                                                                                                                                                                                                           positive cytology: 25%\                                                                                                  
                                                                                                                                                                                                           negative cytology: 74.5%                                                                                                 

  17                                Hasbahceci \[[@cit0024]\]       2018                  34                Cytology                          Neo- CTH                           Before gastrectomy        2 (5.9)                                                                                                                  

  After gastrectomy                 1 (2.9)                                                                                                                                                                                                                                                                                         

  18                                Ronellenfitsch \[[@cit0025]\]   2018                  27                Cytology                          Gastrectomy                        2 (11)                                                                                                                                             

  Gastrectomy + peritoneal lavage   8 (29.6)                                                                                                                                                                                                                                                                                        

  19                                Virgilio \[[@cit0026]\]         2018                  80                Cytology                          Lack                               36 (45)                   Survival: 23 months                                                                                                      
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CTH -- chemotherapy, neo-CTH -- neoadjuvant chemotherapy, aCTH -- adjuvant chemotherapy, RT-PCR -- reverse transcription polymerase chain reaction

###### 

Analysis of frequency of detection of intraperitoneal free cancer cells in gastric cancer using cytology + RT-PCR, RT-PCR and cytology + RT-PCR + cell culture as a diagnostic method

  Method                             First author                 Proportion of positive results and confidence interval
  ---------------------------------- ---------------------------- --------------------------------------------------------
  Cytology + RT-PCR                  Hao \[[@cit0011]\]           0.40 (95% CI: 0.29--0.51)
  0.44 (95% CI: 0.33--0.56)                                       
  RT-PCR                             Wong \[[@cit0018]\]          0.37 (95% CI: 0.30--0.45)
  Fuijwara \[[@cit0021]\]            0.43 (95% CI: 0.35--0.52)    
  Cytology + RT-PCR + cell culture   Takebayashi \[[@cit0020]\]   0.44 (95% CI: 0.34--0.54)

RT-PCR -- reverse transcription polymerase chain reaction

![Algorithm presenting the method of selecting scientific publications for this review](WO-24-94724-g001){#f0001}

![Meta-analysis of the frequency of detection of IFCCs in gastric cancer using cytology as a diagnostic method](WO-24-94724-g002){#f0002}

Results {#sec3}
=======

In cytological examination of peritoneal lavage, in patients with GC, free cancer cells are detected with the frequency 6.25--54.4%. Various factors contribute to the result of cytological examination, including the depth of tumour infiltration, the degree of its differentiation, use of chemotherapy, surgical procedures or lymphadenectomy \[[@cit0003], [@cit0005], [@cit0011], [@cit0015], [@cit0020], [@cit0024]\].

[Table 1](#t0001){ref-type="table"} presents the results of the analysed studies.

Details on meta-analytical method:

-   random effects model,

-   inverse variance method,

-   DerSimonian-Laird estimator for tau^2^,

-   Clopper-Pearson confidence interval for individual studies.

Cytological examination of peritoneal lavage is considered as a gold standard in confirmation of the presence of free cancer cells in the peritoneal cavity, but its sensitivity is very low. The final meta-analysis result of the frequency of detection of IFCCs in GC using cytology as a diagnostic method indicates that the percentage of positive results is 18% (95% CI: 14--24%).

Discussion {#sec4}
==========

Cytological examination applied independently for the detection of free cancer cells is characterized by relatively low sensitivity \[[@cit0009], [@cit0010], [@cit0012], [@cit0018]\]. In order to increase the sensitivity of detection of free cancer cells it is necessary to apply the techniques of molecular biology. Fujiwara *et al.* \[[@cit0015]\] conducted a study comparing the effectiveness of detection of IFCCs using classical cytology and RT-PCR. The study included 137 patients. The material for research was obtained by applying peritoneal lavage using 100 ml of saline. After gentle stirring, 50 ml of the lavage fluid was collected from the peritoneal cavity. A half of the sample was designed for cytological examination, and the other half for RT-PCR assay. A positive result of cytology was observed in 20% of patients, whereas a positive result of the RT-PCR carcinoembryonic antigen mRNA was observed in 54% of patients. In addition, a poorer prognosis was noted in the form of shorter survival of patients with a positive result of RT-PCR assay. The researchers considered a positive result of RT-PCR as an independent prognostic factor. RT-PCR assay increases the sensitivity of detection of IFCCs of patients with GC \[[@cit0015]\]. Presence of IFCCs is classified as metastatic disease (M1) in TNM classification and it is associated with poorer prognosis of patients \[[@cit0006]\]. According to the multivariate analysis, RT-PCR analysis with peritoneal lavage in addition to the pathologic N factor was an independent prognostic factor. There have been a number of reports of successful PCR detection in peritoneal lavage specimens in GC that showed important correlations with patient survival or peritoneal recurrence. If high-risk patients are diagnosed on the basis of the PCR test at the time of the staging laparoscopy, preoperative chemotherapy before the operation or more aggressive chemotherapy, such as intra-peritoneal chemotherapy or chemo-hyperthermia, at the time of resection may be justifiable to prevent peritoneal recurrence. Further clinical trials are needed to resolve the clinical issue \[[@cit0015]\]. Wong *et al.* \[[@cit0018]\] in their study also confirmed that RT-PCR assay increases the sensitivity of detection of IFCCs in the peritoneal cavity in patients with GC. In 156 patients, peritoneal lavage was performed during laparoscopy. The lavage fluid obtained was designed for cytological examination and for examination of the carcinoembryonic antigen (CEA) using RT-PCR assay. The presence of IFCCs in cytology was observed in 31 (19.9%) patients, whereas with the use of RT-PCR a positive result was obtained in 58 (37.2%) patients. The RT-PCR examination for CEA is characterized by higher detectability of subclinical intraperitoneal dissemination, and higher sensitivity compared to the classical cytological examination. Takebayashi *et al.* \[[@cit0020]\] assessed the viability of IFCCs and their capability for formation of metastases *in vivo*. The IFCCs were obtained from peritoneal lavage in 102 patients with GC. Subsequently, cancer cells were proliferated on cell cultures. The subsequent stage of the study was injection of cancer cells into the peritoneal cavity of mice. In the study, 24 nude mice were used, which, after the injection of IFCCs, were bred for 6 weeks, and then euthanized with pentobarbital. After laparotomy, the peritoneal nodules were collected for histopathologic examination. Peritoneal nodules histologically equivalent to poorly differentiated adenocarcinoma were found in 4 mice. This study confirmed that IFCCs are capable of formation of intraperitoneal metastases.

The presence of IFCCs in cytological examination from the peritoneal cavity of patients with malignant carcinomas of the gastrointestinal tract is closely correlated with the depth of infiltration of the tumour, the degree of its differentiation, the presence of ascites, macroscopic or microscopic residual tumour, and the occurrence of distant metastases \[[@cit0009], [@cit0011]\]. In their study, Cotte *et al.* \[[@cit0009]\] observed a correlation between the stage of GC and the rate of positive results of cytological tests of the peritoneal lavage fluid. The study enrolled 1,334 patients with gastrointestinal cancer, including 200 patients with GC. The material for cytological examination was obtained using peritoneal lavage with 200 ml of saline. After waiting 2 minutes, 50 ml of the peritoneal fluid was sucked out from the pouch of Douglas; 95.8% positive results of cytology were found in patients with cancer at the pT3/T4 stage, which suggests the exfoliation of cancer cells directly from the primary tumour. The study demonstrated that the presence of IFCCs in peritoneal lavage cytology is not an independent prognostic factor for assessment of the survival of patients and the frequency of recurrences. A positive cytology result for IFCCs does not provide new prognostic information, compared to commonly applied prognostic factors associated with the pTNM classification and the degree of differentiation of the tumour \[[@cit0009]\]. La Torre *et al.* \[[@cit0012]\] also emphasized that a positive result of cytological examination for IFCCs depends on the stage of the cancer. The study included 64 patients with GC. After opening the abdominal cavity, 200 ml of saline was poured into the peritoneal cavity; the liquid was manually dispersed into the pouch of Douglas, paracolic gutters, as well as into the right and left subperitoneal area. Subsequently, 50 ml of the lavage fluid was collected for cytological examination from various sites of the peritoneal cavity. In the study, a positive result was observed of cytology for the IFCCs in 11% of patients; 86% of them showed stage pT3/T4, while in 100% of patients affected lymph nodes were found. In addition, in 71% of patients the degree of differentiation of GC G3/G4 was observed. The results of this study demonstrate that in patients with a positive result of peritoneal cytology, the cancerous process is more advanced and the prognosis is poorer -- opposite to the previously quoted study \[[@cit0009]\].

Radical gastrectomy with lymphadenectomy is considered the main method of treatment of GC. However, in many patients, intraperitoneal recurrence is observed after radical gastrectomy, even when the tumour had been removed with a margin free from cancer cells (resection R0). It is considered that intraperitoneal recurrence is caused by penetration of the tumour via the gastric wall, and spread of cancer cells by the lymph nodes. Nevertheless, intraperitoneal recurrence was also observed in patients with stage T1N0 subjected to gastrectomy, which cannot be explained by the infiltration of cancer into the gastric wall. In addition, it was demonstrated that manipulations of the tumour during surgery increase the concentration of the mRNA carcinoembryonic antigen (CEA) in blood. This shows the possibility of the spread of cancer cells into the lymphatic vessels and stomach cavity during surgical manoeuvres, which may be the source of intraperitoneal dissemination during radical gastrectomy \[[@cit0005]\]. The vast majority of free cancer cells are subject to apoptosis in the peritoneal cavity -- these cells are exposed to mechanical damage or the action of the immune system. However, surgical injury results in the violation of tissue integrity, induces an inflammatory state, and increases the production of proteins promoting angiogenesis. Additionally, there occurs suppression of the immune system and increased adhesion of cancer cells to the peritoneal cavity. Hence, despite the fact that gastrectomy decreases tumour mass, somehow, it facilitates intraperitoneal dissemination \[[@cit0020]\]. In the study by Han *et al.* \[[@cit0005]\], an increase was found in the frequency of detection of IFCCs in patients after gastrectomy with D2 lymphadenectomy. Thirty-eight patients with GC were enrolled in the study. In each of them, gastric cavity lavage was applied via the nasogastric tube using 200 ml of saline before gastrectomy when the duodenum was closed by means of an intestinal clip. Subsequently, the peritoneal cavity was washed using 500 ml of saline prior to and after gastrectomy. After the procedure, the resected stomach was placed in a container with 500 ml of saline, where it was washed for 15 seconds. The lavage fluid was designed for cytological examination. During the surgical procedure, blood and lymphatic vessels were closed by means of clips, bipolar electrodes, or harmonic scalpels. Samples of the lavage fluid were examined using a classical cytological test and RT-PCR. Free cancer cells in the washing from peritoneal lavage prior to gastrectomy were detected in 34.2% of cases, whereas after gastrectomy, this percentage was 39.5% of cases. The researchers emphasized that free cancer cells may be released from the gastric lumen and from open lymphatic vessels while manipulating the tumour. Therefore, every effort should be made during the surgical procedure not to allow their leakage into the peritoneal cavity. In the study by Takebayashi \[[@cit0020]\], peritoneal lavage was applied before and after gastrectomy with lymphadenectomy in 102 patients with GC. The material for the study was obtained by washing the peritoneal cavity with 100 ml of saline prior to and after gastrectomy; 50 ml of the lavage fluid was intended for cytology, while the remaining 50 ml was for the extraction of cDNA and cell culture. Before gastrectomy, IFCCs were found in 44.2% of patients, while directly after gastrectomy they were found in 78.4%. Hasbahceci *et al.* \[[@cit0024]\], in their study of 2018, also examined the peritoneal lavage fluid in patients before and after gastrectomy. After intraoperative examination of the peritoneal cavity, which did not show the presence of metastases in the peritoneum, the peritoneal cavity was washed with 200 ml of saline. A minimum of 1/3 was aspirated from several sites in the peritoneum -- from the site of primary tumour, left and right subperitoneal space and the pouch of Douglas. After performance of gastrectomy, the peritoneal cavity was washed again in the above-described way. Patients with massive intraperitoneal dissemination and patients with surgically inoperable tumours were excluded from the study. The limitation of this study was the inclusion of patients after neoadjuvant chemotherapy and the use of exclusively cytological examination, without application of additional techniques of molecular biology. The results of cytological examination of the lavage fluid from the peritoneal cavity were unsatisfactory. Only 2 positive cytology results were found prior to gastrectomy per 34 examined patients (5.9%). Cytological examination from peritoneal lavage after gastrectomy showed only one positive result (2.9%). The researchers suggested that the use of neoadjuvant chemotherapy may exert an effect on the result of peritoneal lavage cytology.

Material for cytological examination for IFCCs is usually collected during laparotomy or laparoscopy. Pak *et al.* \[[@cit0023]\] developed a method of percutaneous peritoneal lavage as the method minimally invasive for a patient. The main aim of the study was to determine the sensitivity and specificity of percutaneous peritoneal lavage and its safety for the patient. The study comprised 48 patients with GC. In each patient, percutaneous peritoneal lavage was performed -- via the Veress needle 800 ml of warm saline was administered, and subsequently, a minimum of 5 ml of peritoneal fluid was sucked out for cytological examination. After percutaneous peritoneal lavage, laparoscopic peritoneal lavage was performed, and a minimum of 5 ml of peritoneal fluid was taken for cytological examination. In 10 (20.8%) patients, a positive cytology result was observed from percutaneous peritoneal lavage. In all 10 patients, a positive result of cytology of the laparoscopic peritoneal lavage was also found. In 2 patients with a negative result of cytological examination from the fluid obtained by the percutaneous method, the presence of IFCCs was confirmed in cytology obtained by the laparoscopic method. A 95.8% correlation was found between cytological examination of the peritoneal fluid obtained by the percutaneous method and laparoscopic method; 2-year survival of patients with positive cytology was 25%, whereas in those with negative cytology it was 74.5%. Summing up, percutaneous peritoneal lavage is characterized by high sensitivity and specificity, compared to laparoscopic lavage -- the present standard of collection of fluid for cytological examination for IFCCs. This method may be an effective instrument for quick diagnosis of IFCCs in GC.

The first laparoscopic gastrectomy performed due to malignant GC was performed in 1993. Since then, many scientific publications have appeared which emphasize the advantages of laparoscopic gastrectomy: low postoperative morbidity and mortality, higher quality of life after surgery, and a higher long-term survival rate compared to gastrectomy by the open method. Nevertheless, the use of laparoscopic surgery in advanced GC is not commonly accepted. The main concerns related to laparoscopic resections of the stomach due to malignant cancer pertain to the preservation of the margin free from cancer cells, radical character of lymphadenectomy, and whether laparoscopic gastrectomy is conducive to the exfoliation of free cancer cells from the surface of the tumour. For this reason, in 2010, Hao *et al.* \[[@cit0007]\] conducted a study comparing the frequency of occurrence of IFCCs after gastrectomy performed using the laparoscopic technique and an open technique. The study covered 164 patients with GC -- 83 patients had undergone surgery using the laparoscopic technique, and 81 by the open technique. The selection of the surgical method depended on the patient's decision. None of the patients received neoadjuvant chemotherapy. The material for the study was collected by washing the peritoneal cavity with 100 ml of saline at the beginning of the surgery. Subsequently, the lavage fluid was collected for examination after gentle stirring of the gastric content. The subsequent sample was taken before closing the stomach after peritoneal lavage with 500--1000 ml of saline; 50 ml of the sample was intended for cytological examination, while the remaining 50 ml was for RT-PCR. The post-operative IFCCs rate in cytology was 27.7% using gastrectomy by the laparoscopic method, and 29.63% using the open technique. In the RT-PCR assay, the presence of the IFCCs was observed in 32.53% of cases after laparoscopic gastrectomy, and in 35.80% of cases after open gastrectomy. In general, using RT-PCR and cytology, IFCCs were found in 39.76% and 43.20% of cases after laparoscopic gastrectomy and open gastrectomy, respectively. Intraperitoneal metastasis was observed in 18% of patients after laparoscopic gastrectomy, and in 19.75% of patients after gastrectomy by the open method. The median survival of patients with IFCCs was 20 months, while the median survival of patients with a negative result of examination for IFCCs was 31 months. The survival curve of patients after laparoscopic gastrectomy was similar to that after gastrectomy by the open method. Summing up, laparoscopic techniques applied in patients operated on due to GC do not cause an increased risk for the dissemination of free cancer cells in the peritoneal cavity, compared to the open method. In order to decrease the risk of dissemination of cancer cells during the surgical procedure, it is recommended to observe the principles of oncologic surgery, e.g. a radical resection of the tumour with a minimum margin of 5 cm, and protection of the site of incision of abdominal integuments against contamination by the preparation.

In the study by Ronellenfitsch \[[@cit0025]\] of 2018, conducted among patients after gastrectomy with D2 lymphadenectomy, extensive washing of the peritoneal cavity was applied in order to eliminate free cancer cells. The study was discontinued considering the fact that after the surgical procedure free cancer cells were observed in only 11.1% of cases. In none of these cases did extensive peritoneal washing eliminate the presence of free cancer cells, while after washing the presence of free cancer cells was observed in 29.6% of cases. This study suggests that extensive washing of the peritoneal cavity results in dissemination of the free cancer cells in the peritoneal cavity; therefore, this management may be potentially harmful.

In turn, a study by Kuramoto \[[@cit0010]\] published in 2009 demonstrated that peritoneal lavage and the use of intraperitoneal chemotherapy prolongs the 5-year survival of patients with GC. The study included 88 patients with GC who had a positive cytology result for the presence of IFCCs. The patients were randomly assigned to 3 groups in which the following were applied: surgical treatment, surgical treatment with intraperitoneal chemotherapy, and surgical treatment with intraperitoneal chemotherapy and peritoneal lavage. The 5-year survival of patients who had undergone surgical treatment with intraperitoneal chemotherapy and peritoneal lavage was 43.8%, whereas 5-year survival of those who had undergone surgical treatment as the only method was 4.6%. Also, in this group of patients, intraperitoneal recurrence was more rarely observed. Considering the above, the authors of the report recommend the use of intraperitoneal chemotherapy and peritoneal lavage as a standard prophylaxis of intraperitoneal dissemination in patients subjected to resection of the stomach due to cancer.

The prognosis in patients with the diagnosis of intraperitoneal dissemination in GC is very unfavourable \[[@cit0018]\]. It is necessary to establish new strategies for the treatment of patients with advanced GC. One of them is prevention of the spread of cancer cells from the lymphatic vessels by using surgical instruments for closing vessels. Compared to coagulation, the instruments for closing vessels decrease the leakage of lymph from the lymphatic vessels. However, in a study by Takebayashi *et al.* \[[@cit0020]\], despite the use of these instruments, the spread of free cancer cells in the peritoneal cavity was still observed after the procedures of resection of the stomach with lymphadenectomy. This indicates insufficient effectiveness of instruments for closing vessels currently available on the market. It is necessary to improve them from the aspect of prevention of intraperitoneal dissemination during surgical procedures. One of the strategies is the elimination of cancer cells which have already spread in the peritoneal cavity. The presence of the blood-peritoneal barrier is the cause of a poor effect of intravenous chemotherapy in the case of intraperitoneal metastases. The use of hyperthermic intraperitoneal chemoperfusion (HIPEC) allows one to obtain a high concentration of the chemotherapeutic agent in the peritoneal cavity, with a simultaneous low concentration in blood. Moreover, the drug administered into the peritoneal cavity is absorbed and transported via the portal vein to the liver acting on micrometastases which are formed there. Hyperthermia alone causes direct damage to the IFCCs, and apart from this, acts synergistically with the chemotherapeutic drug -- increases its cytotoxicity and the depth of penetration into the metastatic node \[[@cit0007]\]. In intraperitoneal dissemination in GC, the combination of complete cytoreductive surgery with HIPEC is the only method of treatment which allows long-term survival to be achieved. Many scientific studies confirm that the use of HIPEC after cytoreductive surgery as prophylaxis for intraperitoneal dissemination increases 5-year survival and median survival of patients \[[@cit0027]\].

Conclusions {#sec5}
===========

At present, the diagnosis of the presence of IFCCs in the peritoneal cavity is treated equally to the M category according to the 8th edition of the TNM classification by the AJCC. The effectiveness of detection of IFCCs is still imperfect and requires further studies in order to optimize the assessment of the stage of GC. In the case of detection of the presence of IFCCs in patients with GC, the patient should be qualified for chemotherapy, or possibly the use of HIPEC should be considered.
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